Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis

R. Adhikary, D. Ghosh, E. Paramasivam, M. Callister (Leeds, United Kingdom)

Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Session: Diagnosis and management of pleural and mediastinal diseases
Session type: Thematic Poster Session
Number: 2933
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Adhikary, D. Ghosh, E. Paramasivam, M. Callister (Leeds, United Kingdom). Outcomes of bedside talc slurry pleurodesis for malignant pleural effusions: A retrospective analysis. Eur Respir J 2013; 42: Suppl. 57, 2933

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study
Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma
Year: 2014


Thoracoscopic talc Poudrage pleurodesis for malignant effusions
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015

An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


What outcome after pleurodesis in malignant pleural effusion in lung cancer?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Incidence of malignancy in patients with pleural effusion referred for workup by pulmonologists: Diagnostic yield of thoracentesis, and use of other investigational procedures
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



LATE-BREAKING ABSTRACT: Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Comparison between bronchoscopy, closed (Abram’s) and medical thoracoscopic pleural biopsies in undiagnosed pleural effusions
Source: International Congress 2016 – Pleural diseases
Year: 2016


Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Predictive parameters of survival in malignant pleural effusion
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Utility of sending pleural fluid for cytology at the time of thoracoscopy and pleural biopsy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


CT scanner for the pleural staging of pleural cancer: How accurate is this?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014

Outcome of patients with non specific pleuritis after medical thoracoscopy
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015